Title {1}	Effect of Cognitive Behavior Therapy (CBT) on Lowering of Blood Lipid Levels in Atherosclerotic Cardiovascular Disease (ASCVD) Patients: Study Protocol for a Multicenter, Prospective, Randomized Controlled Trial
Trial registration {2a and 2b}.	Chinese Clinical Trial Registry (ChiCTR2100046775) [registered: 2021/5/28].
Protocol version {3}	2021-July-20: Original; version 1.1.
Funding {4}	This trial is funded by the National Natural Science Foundation of China.
Author details {5a}	Xu-Lin Hong, 1028346604@zju.edu.cn; Hong-Ying Liu, hongyingliu@91jkys.com; Yi Luan, ryan1218@zju,edu,cn; Wen-Bin Zhang, 3313011@zju.edu.cn; Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang, China
Name and contact information for the trial sponsor {5b}	Jia Tang, jiatang@91jkys.com; Hangzhou Kang Sheng Health Consulting CO., LTD.
Role of sponsor {5c}	Hangzhou Kang Sheng Health Consulting CO., LTD provides the technology to design the MiniApp “ASCVD CBT” used in interventions. This is an investigator initiated trial. The principal investigator is also the sponsor of this trial. The principal investigator is responsible for the trial design, writing the manuscript, and leading the research team (including the nurses and physicians) to collect data.